Cargando…

Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies

Polycystic ovarian syndrome (PCOS) is an heterogenous, endocrine, metabolic, and multidisciplinary disorder of reproductive-aged females that aggravates insulin resistance, hyperandrogenism, obesity, menstrual irregularities, and infertility. Bitter melon is consumed as vegetable in various parts of...

Descripción completa

Detalles Bibliográficos
Autores principales: Hussain, Liaqat, Aamir, Noor, Hussain, Musaddique, Asif, Muhammad, Chauhdary, Zunera, Manzoor, Faiza, Siddique, Rida, Riaz, Muhammad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536891/
https://www.ncbi.nlm.nih.gov/pubmed/36212951
http://dx.doi.org/10.1155/2022/5143653
_version_ 1784803073273626624
author Hussain, Liaqat
Aamir, Noor
Hussain, Musaddique
Asif, Muhammad
Chauhdary, Zunera
Manzoor, Faiza
Siddique, Rida
Riaz, Muhammad
author_facet Hussain, Liaqat
Aamir, Noor
Hussain, Musaddique
Asif, Muhammad
Chauhdary, Zunera
Manzoor, Faiza
Siddique, Rida
Riaz, Muhammad
author_sort Hussain, Liaqat
collection PubMed
description Polycystic ovarian syndrome (PCOS) is an heterogenous, endocrine, metabolic, and multidisciplinary disorder of reproductive-aged females that aggravates insulin resistance, hyperandrogenism, obesity, menstrual irregularities, and infertility. Bitter melon is consumed as vegetable in various parts of the world. The purpose of this study was to provide the rationale for the folkloric uses of bitter melon (Momordica charantia L.) in reproductive abnormalities. HPLC analysis of standardized aqueous methanolic extract of bitter melon revealed the presence of various phytochemicals such as quercetin, gallic acid, benzoic acid, chlorogenic acid, syringic acid, p-coumaric acid, ferulic acid, and cinnamic acid. Twenty-five Swiss albino adult female rats (120–130 g) were acquired and divided into two groups (5 + 20). Letrozole (1 mg/kg p.o.) was used for four weeks to induce PCOS in twenty rats. Disease induction was confirmed by vaginal smear cytology analysis under the microscope. Animals were further divided into four groups, with one group as PCOS group, and the remaining three are treated with standardized extract of bitter melon (500 mg/kg p.o.), bitter melon plus metformin (500 mg/kg p.o.), and metformin alone for the period of next four weeks. After four weeks, the rats were euthanized at diestrus stage. Ovaries of the experimental animals were removed and fixed in 10% buffered formalin, and blood samples were obtained from direct cardiac puncture and stored. Ovaries histopathological analysis showed cystic follicles (9–10) in PCOS group, while, in all the treatment groups, we found developing and mature follicles. Similarly, hormone analysis showed significant (p < 0.001) reduction of LH surge, insulin, and testosterone levels and improvement in FSH levels. Lipid profile and antioxidant enzymes status were also significantly (p < 0.001) improved. In conclusion, the study validates the bitter melon potential as an insulin sensitizer and ovulation enhancer and authenticates its potential in PCOS management.
format Online
Article
Text
id pubmed-9536891
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-95368912022-10-07 Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies Hussain, Liaqat Aamir, Noor Hussain, Musaddique Asif, Muhammad Chauhdary, Zunera Manzoor, Faiza Siddique, Rida Riaz, Muhammad Evid Based Complement Alternat Med Research Article Polycystic ovarian syndrome (PCOS) is an heterogenous, endocrine, metabolic, and multidisciplinary disorder of reproductive-aged females that aggravates insulin resistance, hyperandrogenism, obesity, menstrual irregularities, and infertility. Bitter melon is consumed as vegetable in various parts of the world. The purpose of this study was to provide the rationale for the folkloric uses of bitter melon (Momordica charantia L.) in reproductive abnormalities. HPLC analysis of standardized aqueous methanolic extract of bitter melon revealed the presence of various phytochemicals such as quercetin, gallic acid, benzoic acid, chlorogenic acid, syringic acid, p-coumaric acid, ferulic acid, and cinnamic acid. Twenty-five Swiss albino adult female rats (120–130 g) were acquired and divided into two groups (5 + 20). Letrozole (1 mg/kg p.o.) was used for four weeks to induce PCOS in twenty rats. Disease induction was confirmed by vaginal smear cytology analysis under the microscope. Animals were further divided into four groups, with one group as PCOS group, and the remaining three are treated with standardized extract of bitter melon (500 mg/kg p.o.), bitter melon plus metformin (500 mg/kg p.o.), and metformin alone for the period of next four weeks. After four weeks, the rats were euthanized at diestrus stage. Ovaries of the experimental animals were removed and fixed in 10% buffered formalin, and blood samples were obtained from direct cardiac puncture and stored. Ovaries histopathological analysis showed cystic follicles (9–10) in PCOS group, while, in all the treatment groups, we found developing and mature follicles. Similarly, hormone analysis showed significant (p < 0.001) reduction of LH surge, insulin, and testosterone levels and improvement in FSH levels. Lipid profile and antioxidant enzymes status were also significantly (p < 0.001) improved. In conclusion, the study validates the bitter melon potential as an insulin sensitizer and ovulation enhancer and authenticates its potential in PCOS management. Hindawi 2022-09-29 /pmc/articles/PMC9536891/ /pubmed/36212951 http://dx.doi.org/10.1155/2022/5143653 Text en Copyright © 2022 Liaqat Hussain et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Hussain, Liaqat
Aamir, Noor
Hussain, Musaddique
Asif, Muhammad
Chauhdary, Zunera
Manzoor, Faiza
Siddique, Rida
Riaz, Muhammad
Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies
title Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies
title_full Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies
title_fullStr Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies
title_full_unstemmed Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies
title_short Therapeutic Investigation of Standardized Aqueous Methanolic Extract of Bitter Melon (Momordica charantia L.) for Its Potential against Polycystic Ovarian Syndrome in Experimental Animals' Model: In Vitro and In Vivo Studies
title_sort therapeutic investigation of standardized aqueous methanolic extract of bitter melon (momordica charantia l.) for its potential against polycystic ovarian syndrome in experimental animals' model: in vitro and in vivo studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536891/
https://www.ncbi.nlm.nih.gov/pubmed/36212951
http://dx.doi.org/10.1155/2022/5143653
work_keys_str_mv AT hussainliaqat therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies
AT aamirnoor therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies
AT hussainmusaddique therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies
AT asifmuhammad therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies
AT chauhdaryzunera therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies
AT manzoorfaiza therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies
AT siddiquerida therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies
AT riazmuhammad therapeuticinvestigationofstandardizedaqueousmethanolicextractofbittermelonmomordicacharantialforitspotentialagainstpolycysticovariansyndromeinexperimentalanimalsmodelinvitroandinvivostudies